Exact Sciences Corporation Surges to 485th in Trading Rankings with $219 Million Turnover

On May 14, 2025, Exact Sciences Corporation (EXAS) saw a significant increase in trading volume, with a turnover of $219 million, marking a 73.7% rise from the previous day. This surge placed EXAS at the 485th position in the day's trading rankings. The stock price of EXAS also rose by 2.24%, marking the third consecutive day of gains, with a total increase of 6.28% over the past three days.

Exact Sciences Corporation recently participated in the BofA Securities 2025 Healthcare Conference, where they presented their latest developments and strategies. This event provided a platform for the company to showcase its advancements in cancer screening and diagnostic technologies, which are crucial for its market position and investor confidence.

In a significant financial transaction, MDxHealth made a $28.0 million earnout payment to Exact Sciences on April 29, 2025. This payment is part of a larger financial agreement between the two companies, highlighting the ongoing collaboration and financial health of Exact Sciences.